Patent Assignment
Reel/Frame 062228/0763
Patent Security Agreement
Recorded: 2022-12-27
Pages: 13
Assignor
ADC THERAPEUTICS SA
Executed: 2022-08-15
Assignee
OWL ROCK OPPORTUNISTIC MASTER FUND I, L.P.
399 PARK AVENUE, 38TH FLOOR, NEW YORK, NEW YORK, 10022
Covered Properties
(46)
Polynucleotides and Polypeptide Sequences Involved in Cancer
Anti-Kidney Associated Antigen 1 (KAAG1) Antibodies
Antibodies That Specifically Block the Biological Activity of Kidney Associated Antigen 1 (KAAG1)
Antibodies Against Kidney Associated Antigen 1 and Antigen Binding Fragments Thereof
Pyrrolobenzodiazepine-Antibody Conjugates
Pyrrolobenzodiazepine-Anti-Psma Antibody Conjugates
Pyrrolobenzodiazepine-Antibody Conjugates
Pyrrolobenzodiazepine-Antibody Conjugates
Pyrrolobenzodiazepine-Anti-CD22 Antibody Conjugates
Antibodies Against Kidney Associated Antigen 1 and Antigen Binding Fragments Thereof
Pyrrolobenzodiazepine-Antibody Conjugates
Pyrrolobenzodiazepine-Antibody Conjugates
Antibodies Against Kidney Associated Antigen 1 and Antigen Binding Fragments Thereof
Pyrrolobenzodiazepine-Antibody Conjugates
Antibodies Against Kidney Associated Antigen 1 and Antigen Binding Fragments Thereof
Pyrrolobenzodiazepine-Anti-CD22 Antibody Conjugates
Pyrrolobenzodiazepine-Antibody Conjugates
Pyrrolobenzodiazepine-Antibody Conjugates
Method for Treating Breast Cancer
Combination Therapy with an Anti-Axl Antibody-Drug Conjugate
Pyrrolobenzodiazepine-Antibody Conjugates
Pyrrolobenzodiazepine-Antibody Conjugates
Combination Therapy with an Anti-Axl Antibody-Drug Conjugate
Application:
16/605,692 →
Publication:
US 2020/0129637
Combination Therapy
Application:
16/605,701 →
Publication:
US 2020/0405879
Combination Therapy with an Anti-CD25 Antibody-Drug Conjugate
Dosage Regimes for the Administration of an Anti-CD19 Adc
Dosage Regimes for the Administration of an Anti-CD25 Adc
Site-Specific Antibody-Drug Conjugates
Pyrrolobenzodiazepine-Antibody Conjugates
Application:
16/806,910 →
Publication:
US 2020/0405873
Pyrrolobenzodiazepine-Anti-CD22 Antibody Conjugates
Pyrrolobenzodiazepine-Antibody Conjugates
Treatment of Car T-Cell Toxicity
Application:
16/968,143 →
Publication:
US 2022/0175948
Pyrrolobenzodiazepine-Anti-Psma Antibody Conjugates
Application:
16/987,348 →
Publication:
US 2021/0137940
Pyrrolobenzodiazepine-Antibody Conjugates
Pyrrolobenzodiazepine-Antibody Conjugates
Application:
17/006,681 →
Publication:
US 2021/0113587
Molecular Adjuvant
Application:
17/057,486 →
Publication:
US 2022/0111065
Combination Therapy
Application:
17/259,466 →
Publication:
US 2023/0132256
Combination Therapy
Application:
17/271,108 →
Publication:
US 2021/0322564
Pyrrolobenzodiazepine-Antibody Conjugates
Anti-IL13R ALPHA2 Antibodies
Pyrrolobenzodiazepine Resistance
Application:
17/414,622 →
Publication:
US 2022/0347309
Pyrrolobenzodiazepine-Antibody Conjugates and Uses Thereof
Application:
17/481,918 →
Publication:
US 2022/0096654
Pyrrolobenzodiazepine-Antibody Conjugates
Combination Therapy Comprising an Anti-CD25 Antibody Drug Conjugate and a Further Agent
Application:
17/617,864 →
Combination Therapy Comprising an Anti-CD19 Antibody Drug Conjugate and a PI3K Inhibitor or a Secondary Agent
Application:
17/617,875 →
Publication:
US 2022/0305132
Dosage Regimes for the Administration of an Anti-CD19 Adc
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 18, 2008
From: SOOKNANAN, ROY RABINDRANAUTH; TREMBLAY, GILLES BERNARD; FILION, MARIO
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 022005/0351 →
Assignment of Assignor's Interest
Mar 29, 2012
From: SULEA, TRAIAN
To: NATIONAL RESEARCH COUNCIL OF CANADA
Reel/Frame 027952/0500 →
Assignment of Assignor's Interest
Mar 29, 2012
From: TREMBLAY, GILLES BERNARD; FILION, MARIO
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 027952/0754 →
Assignment of Assignor's Interest
Mar 19, 2013
From: TREMBLAY, GILLES BERNARD; FILION, MARIO
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 030041/0863 →
Assignment of Assignor's Interest
Mar 19, 2013
From: SULEA, TRAIAN
To: NATIONAL RESEARCH COUNCIL OF CANADA
Reel/Frame 030041/0918 →
Assignment of Assignor's Interest
Oct 17, 2013
From: NATIONAL RESEARCH COUNCIL OF CANADA
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 031425/0017 →
Assignment of Assignor's Interest
Oct 31, 2013
From: NATIONAL RESEARCH COUNCIL OF CANADA
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 031519/0773 →
Assignment of Assignor's Interest
Dec 12, 2013
From: TREMBLAY, GILLES BERNARD; MORAITIS, ANNA N.; FILION, MARIO
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 031766/0935 →
Assignment of Assignor's Interest
Dec 12, 2013
From: SULEA, TRAIAN
To: NATIONAL RESEARCH COUNCIL OF CANADA
Reel/Frame 031766/0876 →
Assignment of Assignor's Interest
Dec 12, 2013
From: NATIONAL RESEARCH COUNCIL OF CANADA
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 031767/0056 →
Assignment of Assignor's Interest
Mar 22, 2016
From: SULEA, TRAIAN
To: NATIONAL RESEARCH COUNCIL OF CANADA
Reel/Frame 038071/0204 →
Assignment of Assignor's Interest
Mar 22, 2016
From: NATIONAL RESEARCH COUNCIL OF CANADA
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 038071/0421 →
Assignment of Assignor's Interest
Mar 22, 2016
From: TREMBLAY, GILLES BERNARD; MORAITIS, ANNA N.; FILION, MARIO
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 038071/0075 →
Assignment of Assignor's Interest
May 10, 2016
From: VAN BERKEL, PATRICIUS HENDRIKUS CORNELIS
To: ADC THERAPEUTICS SÀRL
Reel/Frame 038538/0278 →
Assignment of Assignor's Interest
May 10, 2016
From: HOWARD, PHILIP WILSON
To: MEDIMMUNE LIMITED
Reel/Frame 038537/0195 →
Assignment of Assignor's Interest
May 10, 2016
From: MEDIMMUNE LIMITED
To: SPIROGEN SÀRL
Reel/Frame 038537/0409 →
Assignment of Assignor's Interest
May 10, 2016
From: HOWARD, PHILIP WILSON
To: MEDIMMUNE LIMITED
Reel/Frame 038537/0975 →
Change of Name
May 10, 2016
From: ADC THERAPEUTICS SÀRL
To: ADC THERAPUETICS SA
Reel/Frame 038537/0843 →
Assignment of Assignor's Interest
May 10, 2016
From: VAN BERKEL, PATRICIUS HENDRIKUS CORNELIS
To: ADC THERAPEUTICS SÀRL
Reel/Frame 038537/0717 →
Confirmatory Assignment
May 10, 2016
From: SPIROGEN SÀRL
To: MEDIMMUNE LIMITED
Reel/Frame 038658/0786 →
Confirmatory Assignment
May 10, 2016
From: SPIROGEN SÀRL
To: MEDIMMUNE LIMITED
Reel/Frame 038659/0578 →
Assignment of Assignor's Interest
May 10, 2016
From: MEDIMMUNE LIMITED
To: SPIROGEN SÀRL
Reel/Frame 038538/0103 →
Change of Name
May 10, 2016
From: ADC THERAPEUTICS SÀRL
To: ADC THERAPUETICS SA
Reel/Frame 038538/0370 →
Assignment of Assignor's Interest
Sep 20, 2016
From: VAN BERKEL, PATRICIUS HENDRIKUS CORNELIS
To: A.T. DEVELOPMENT SWITZERLAND SÀRL
Reel/Frame 039790/0855 →
Assignment of Assignor's Interest
Sep 20, 2016
From: A.T. DEVELOPMENT SWITZERLAND SÀRL
To: ADC THERAPEUTICS S.A.
Reel/Frame 039790/0982 →